Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs.

Pasipanodya JG, Gumbo T.

Curr Opin Pharmacol. 2011 Oct;11(5):457-63. doi: 10.1016/j.coph.2011.07.001. Epub 2011 Jul 30. Review.

2.

Optimizing the clinical pharmacology of tuberculosis medications.

Egelund EF, Alsultan A, Peloquin CA.

Clin Pharmacol Ther. 2015 Oct;98(4):387-93. doi: 10.1002/cpt.180. Epub 2015 Jul 22. Review.

PMID:
26138226
3.

Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis.

Garg T, Rath G, Murthy RR, Gupta UD, Vatsala PG, Goyal AK.

Curr Pharm Des. 2015;21(22):3076-89. Review.

PMID:
26027577
4.

Drug-Resistant Tuberculosis: Challenges and Progress.

Kurz SG, Furin JJ, Bark CM.

Infect Dis Clin North Am. 2016 Jun;30(2):509-522. doi: 10.1016/j.idc.2016.02.010. Review.

5.

Antibiotic resistance mechanisms in M. tuberculosis: an update.

Nguyen L.

Arch Toxicol. 2016 Jul;90(7):1585-604. doi: 10.1007/s00204-016-1727-6. Epub 2016 May 9. Review.

7.

Mechanisms of drug resistance in Mycobacterium tuberculosis.

Zhang Y, Yew WW.

Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30. Review.

PMID:
19861002
8.

Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach.

Pranger AD, Alffenaar JW, Aarnoutse RE.

Curr Pharm Des. 2011;17(27):2900-30. Review.

PMID:
21834759
10.

Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.

Viveiros M, Martins M, Rodrigues L, Machado D, Couto I, Ainsa J, Amaral L.

Expert Rev Anti Infect Ther. 2012 Sep;10(9):983-98. doi: 10.1586/eri.12.89. Review.

PMID:
23106274
11.

Multi-drug resistant tuberculosis burden and risk factors: an update.

Marahatta SB.

Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):116-25. Review.

PMID:
21209520
12.

Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.

Wasserman S, Meintjes G, Maartens G.

Expert Rev Anti Infect Ther. 2016 Oct;14(10):901-15. doi: 10.1080/14787210.2016.1225498. Epub 2016 Aug 27. Review.

PMID:
27532292
13.

Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.

Zhang Y, Yew WW.

Int J Tuberc Lung Dis. 2015 Nov;19(11):1276-89. doi: 10.5588/ijtld.15.0389. Review.

PMID:
26467578
14.

[Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].

Tungusova OS, Mar'iandyshev AO.

Probl Tuberk. 2001;(6):48-9. Review. Russian. No abstract available.

PMID:
11641963
15.

Advances in the treatment of tuberculosis.

Zhang Y.

Clin Pharmacol Ther. 2007 Nov;82(5):595-600. Epub 2007 Sep 26. Review.

PMID:
17898708
16.

[The problem of resistance in the treatment of Mycobacterium infections: new experimental results and combinations for the treatment of tuberculosis and leprosy].

Seydel JK, Schaper KJ.

Pharm Unserer Zeit. 1995 Nov;24(6):313-23. Review. German. No abstract available.

PMID:
8592712
17.

Molecular genetics of drug resistance in Mycobacterium tuberculosis.

Zhang Y, Young D.

J Antimicrob Chemother. 1994 Sep;34(3):313-9. Review.

PMID:
7829406
18.

[Resistant tuberculosis: a molecular review].

Rossetti ML, Valim AR, Silva MS, Rodrigues VS.

Rev Saude Publica. 2002 Aug;36(4):525-32. Review. Portuguese.

19.

Inhibition of drug efflux in mycobacteria with phenothiazines and other putative efflux inhibitors.

Rodrigues L, AĆ­nsa JA, Amaral L, Viveiros M.

Recent Pat Antiinfect Drug Discov. 2011 May;6(2):118-27. Review.

PMID:
21517739
20.

Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis.

Dooley KE, Mitnick CD, Ann DeGroote M, Obuku E, Belitsky V, Hamilton CD, Makhene M, Shah S, Brust JC, Durakovic N, Nuermberger E; Efficacy Subgroup, RESIST-TB.

Clin Infect Dis. 2012 Aug;55(4):572-81. Epub 2012 May 21. Review.

Supplemental Content

Support Center